Evaluation of the APRI (AST, platelet ratio index) and ELF™ (Enhanced Liver Fibrosis) tests to detect significant fibrosis due to chronic hepatitis C

Podobne zapisy

• Performance of the AST to Platelet Ratio Index (APRI) as a Noninvasive Marker of Fibrosis in Pediatric Patients with Chronic Viral Hepatitis
  od: McGoogan, Katherine E., i wsp.
  Wydane: (2010)
• AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects
  od: De Matteis, Carlo, i wsp.
  Wydane: (2021)
• Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
  od: Adler, Michael
  Wydane: (2011)
• Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease
  od: Anania, Caterina, i wsp.
  Wydane: (2011)
• Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease
  od: Fallatah, Hind I., i wsp.
  Wydane: (2016)